Harnessing immune system responses against cancer cells ushered a 
new era for oncology. Deciphering the mechanisms of cancer cell de-
regulation and resistance to conventional treatments resulted in pre-
clinical evidence-based findings and translated into groundbreaking 
clinical results with substantial impact on survival and quality of life of 
some cancer patients even of terminal stage.